The federal government in September 2024 sued the country’s three largest pharmacy benefit managers for allegedly inflating the list price of insulin drugs.
Noah Tong is a Staff Writer covering health payers at various prominent publications. He focuses on themes such as healthcare systems, consumer health, and the intersection of health and economics, delving into topics like patient care, healthcare administration, and public health. Noah's work has been featured in Corridor Business Journal, FierceHealth, RamaOnHealthcare, Modern Healthcare, and Crain's Chicago Business.












